← Back to Analyst Consensus 
NMTC Buy
NEUROONE MEDICAL TECHNOLOGIES Corp
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | Maxim Group | maintain | Buy → Buy | — | 42% |
| May 13, 2026 | Ladenburg Thalmann | maintain | Buy → Buy | — | 45% |
| Mar 2, 2026 | Jones Trading | initiate | — → Buy | — | 50% |
| Sep 9, 2025 | Maxim Group | initiate | — → Buy | $3 | 42% |
| May 5, 2025 | Ladenburg Thalmann | initiate | — → Buy | $1.45 | 45% |
| Aug 15, 2023 | Alliance Global Partners | maintain | Buy → Buy | $2.2 | 41% |
| Mar 28, 2022 | Craig-Hallum | downgrade | Buy → Hold | $0 | 54% |
| Dec 3, 2021 | Alliance Global Partners | initiate | — → Buy | $5.75 | 41% |
| Nov 15, 2021 | Craig-Hallum | initiate | — → Buy | $6 | 54% |
Price Target Trend
Apr 1, 2026 Latest: $7.27 Oct 25, 2026
EPS Estimates
+1y $-0.63
Lo: $-0.78 Hi: $-0.41
3 analysts 0y $-0.71
Lo: $-0.88 Hi: $-0.39
3 analysts ▲1
0q $-0.19
Lo: $-0.20 Hi: $-0.19
3 analysts +1q $-0.17
Lo: $-0.22 Hi: $-0.14
3 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days